Skip to main content
. 2021 Jun 17;12:639207. doi: 10.3389/fphar.2021.639207
Authors contributing to the ESAC-Net study group:
Austria Reinhild Strauss Federal Ministry for Social Affairs, Health, Care and Consumer Protection
Belgium Eline Vandael Sciensano
Bulgaria Ivan N. Ivanov National Center of Infectious and Parasitic Diseases
Croatia Marina Payerl-Pal The Interdisciplinary Section for Antibiotic Resistance Control, Ministry of Health
Cyprus Isavella Kyriakidou Pharmaceutical Services, Ministry of Health
Denmark Majda Attauabi Statens Serum Institut
Estonia Elviira Linask Estonian State Agency of Medicines
France KarimaHider - Mlynarz EPI-PHARE, epidemiology of health products (French National Agency for the Safety of Medicines and Health Products, and French National Health Insurance)
Germany Birgitta Schweickert Robert Koch Institute, Department: Healthcare-associated Infections, Surveillance of Antimicrobial Resistance and Consumption, Berlin
Hungary Ria Benkö University of Szeged, Department of Clinical Pharmacy, Albert Szent Györgyi Health Center, Central Pharmacy and Department of Emergency Medicine
Iceland Guðrún Aspelund Center for Health Security and Communicable Disease Control, Directorate of Health, Reykjavik
Ireland Karen Burns Health Protection Surveillance Center, Dublin
Italy Filomena Fortinguerra Italian Medicines Agency (AIFA), Rome
Latvia Ieva Rutkovska Centre for Disease Prevention and Control, Department of Infectious Disease Surveillance and Immunization, Riga
Luxembourg Martine Trauffler Division of Pharmacy and Medicines, Directorate of Health
Malta Peter Zarb National Antibiotic Committee
Netherlands Stephanie Natsch Department of Pharmacy, Radboud university medical center, Nijmegen
Norway Hege Salvesen Blix Norwegian Institute of Public Health
Poland Anna Olczak-Pieńkowska National Medicines Institute, Department of Epidemiology and Clinical Microbiology
Portugal Ana Silva INFARMED - National Authority of Medicines and Health Products, I.P.
Romania Ionel Iosif National Institute of Public Health, National Center for Disease Prevention and Control, Bucharest
Slovakia Tomáš Tesař Department of Organization and Management in Pharmacy, Pharmaceutical Faculty, Comenius University in Bratislava
Slovenia Milan Cižman University Medical Center, Department of Infectious Diseases, Ljubljana
Spain Mayte Alonso National Agency for Drugs and Medical Devices
Sweden Vendela Bergfeldt Public Health Agency of Sweden
United Kingdom Susan Hopkins National Infection Service, Public Health England
Authors contributing to the WHO Europe AMC Network study group:
Albania Narvina Sinani National Agency for Drugs and Medical Devices
Armenia Lilit Ghazaryan Scientific Center of Drug and Medical Technology Expertize of Ministry of Health
Azerbaijan Fikriyya Ibrahimli Analytical Expertize Center of Ministry of Health
Bosnia and Herzegovina Tijana Spasojević Sector for Providing Information on Drugs and Medical Products in Agency for Medicinal Products and Medical Devices of Bosnia and Herzegovina
Belarus Halina Pyshnik Department of Organization of Medicines Supply, Ministry of Health
Georgia Marine Baidauri Health Policy Division of Policy Department Ministry of IDPs, Labor, Health and Social Affairs of Georgia
Kazakhstan Larissa Makalkina Department of Clinical Pharmacology, Astana Medical University Republican Public Union "Professional Association of Clinical Pharmacologists and Pharmacists"
Kyrgyzstan Aizhan Tabaldyeva Unit on Specialized Expertize of Medicines of Department of Drug Provision and Medical Devices, Ministry of Health
Republic of Moldova Angela Carp P.I. Coordination, Implementation and Monitoring Unit of the Health System Projects
Montenegro Lidija Čizmović Department for Establishing Maximum Prices and Monitoring Consumption of Medicines, Agency for Medicines and Medical Devices
Russian Federation Svetlana Rachina Internal Medicine Department №2, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation
Serbia Milica Bajčetić Department of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade, Serbia
Tajikistan Nargis Kalandarova Department of Conformity Assessment of Medicines of the State Unitary Enterprise for Examination and Testing Pharmaceutical and Medical Products of the State Service Health and Social Protection of Population Supervision
Turkey Mesil Aksoy Department of Rational Use of Medicines. Turkish Medicines and Medical Devices Agency, Ministry of Health of Turkey
Uzbekistan Mukhabbat Ibragimova Agency on Development of the Pharmaceutical Industry under the Ministry of Health of the Republic of Uzbekistan. Head of Information and Analytics Department